Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.56 -0.61 (-3.18%)
At close: Oct 21, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) EV to CFO (2020 - 2026)

Updated

Sarepta Therapeutics' (SRPT) EV to CFO came in at 10.00 for Q2 2026, up 6.6% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) EV to CFO (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to CFO at Sarepta Therapeutics was -12.02; for FY2020, it came in at 107.80.

  • The Q2 2026 figure stands as the highest quarterly EV to CFO since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Sarepta Therapeutics 1.96 Bn -1.27 Bn 251.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.00
Mar 31, 2026 9.38
Dec 31, 2020 107.80
Sep 30, 2020 78.16
Jun 30, 2020 36.35
Mar 31, 2020 17.15
API Access

Sarepta Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SRPT&period=max&api_key=YOUR_API_KEY